Candel Therapeutics, Inc. (CADL) Balance Sheet
As of 2026-06-30 (10-Q), Candel Therapeutics, Inc. (CADL) reported total assets of $208.1M, total liabilities of $82.0M and shareholders' equity of $126.1M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $201.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CADLCandel Therapeutics, Inc.Follow CADL — free
—
Price chart with a free account
- Market cap
- 614.4M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 82.6 | 70.1 | 35.4 | 102.7 | 119.7 | 201.6 | |
| Current assets | 84.9 | 71.9 | 36.8 | 103.8 | 121.4 | 204.2 | |
| Total assets | 89.2 | 77.7 | 41.2 | 106.9 | 125.2 | 208.1 | |
| Current liabilities | 5.4 | 5.6 | 14.2 | 37.5 | 9.0 | 12.7 | |
| Long-term debt | 0.6 | — | 11.6 | 1.7 | — | — | |
| Short-term debt | — | — | 8.9 | 9.9 | 0.0 | — | |
| Total liabilities | 25.1 | 30.0 | 28.5 | 40.5 | 73.3 | 82.0 | |
| Shareholders' equity | 64.1 | 47.7 | 12.7 | 66.3 | 51.9 | 126.1 |
USD millions · SEC XBRL
Candel Therapeutics, Inc. — questions
- How much cash does Candel Therapeutics, Inc. have?
- $201.6M in cash and cash equivalents as of 2026-06-30.
- What are Candel Therapeutics, Inc.'s total assets?
- $208.1M as of 2026-06-30.
- What is Candel Therapeutics, Inc.'s shareholders' equity?
- $126.1M as of 2026-06-30.
Every figure on this page comes from Candel Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.